Which are the demographic and clinical characteristics of patients who respond to subcutaneous esketamine?

American Psychiatric Association (1994) Diagnostical and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. Washington, D.C.: American Psychiatric Association.

American Psychiatric Association (2013) Diagnostical and Statistical Manual of Mental Disorders (DSM-5), 5th edn. Arlington, VA: American Psychiatric Association.

Fekadu A Wooderson SC Markopoulou K , et al. (2009) The Maudsley Staging Method for treatment-resistant depression: Prediction of longer-term outcome and persistence of symptoms. J Clin Psychiatry 70: 952–957.

Lucchese AC Sarin LM Magalhães EJM , et al. (2021) Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity. J Psychopharmacol 35: 142–149.